Leveraging preclinical models of metastatic breast cancer

DA Pedroza, Y Gao, XHF Zhang, JM Rosen - Biochimica et Biophysica Acta …, 2024 - Elsevier
Women that present to the clinic with established breast cancer metastases have limited
treatment options. Yet, the majority of preclinical studies are actually not directed at …

FOXC2 promotes vasculogenic mimicry and resistance to anti-angiogenic therapy

IG Cannell, K Sawicka, I Pearsall, SA Wild, L Deighton… - Cell Reports, 2023 - cell.com
Vasculogenic mimicry (VM) describes the formation of pseudo blood vessels constructed of
tumor cells that have acquired endothelial-like properties. VM channels endow the tumor …

Metabolism of asparagine in the physiological state and cancer

Q Yuan, L Yin, J He, Q Zeng, Y Liang, Y Shen… - Cell Communication and …, 2024 - Springer
Asparagine, an important amino acid in mammals, is produced in several organs and is
widely used for the production of other nutrients such as glucose, proteins, lipids, and …

Immune checkpoint inhibitors in first-line therapies of metastatic or early triple-negative breast cancer: a systematic review and network meta-analysis

X Liang, X Chen, H Li, Y Li - Frontiers in Endocrinology, 2023 - frontiersin.org
Background The optimal first-line immune checkpoint inhibitor (ICI) treatment strategy for
metastatic or early triple-negative breast cancer (TNBC) has not yet been determined as a …

Cancer Research in the Age of Spatial Omics: Lessons from IMAXT

D Bressan… - Cancer …, 2025 - aacrjournals.org
The Imaging and Molecular Annotation of Xenografts and Tumors Cancer Grand Challenges
team was set up with the objective of developing the “next generation” of pathology and …